Pharmacogenetics and individualizing drug treatment during pregnancy
dc.contributor.author | Haas, David M. | |
dc.contributor.department | Department of Obstetrics and Gynecology, IU School of Medicine | en_US |
dc.date.accessioned | 2016-07-01T16:59:05Z | |
dc.date.available | 2016-07-01T16:59:05Z | |
dc.date.issued | 2014-01 | |
dc.description.abstract | Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Haas, D. M. (2014). Pharmacogenetics and individualizing drug treatment during pregnancy. Pharmacogenomics, 15(1), 69–78. http://doi.org/10.2217/pgs.13.228 | en_US |
dc.identifier.issn | 1744-8042 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/10281 | |
dc.language.iso | en_US | en_US |
dc.publisher | Future Medicine | en_US |
dc.relation.isversionof | 10.2217/pgs.13.228 | en_US |
dc.relation.journal | Pharmacogenomics | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Pharmacogenetics | en_US |
dc.subject | Precision Medicine | en_US |
dc.subject | Pregnancy Complications | en_US |
dc.subject | pathology | en_US |
dc.title | Pharmacogenetics and individualizing drug treatment during pregnancy | en_US |
dc.type | Article | en_US |